Purchases and Sales Made in Q3 2023 in Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO) during Q3 2023. The information is specifically focused on institutions that hold shares of Xilio Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
8.57K+ 47.92% |
$18.1K - $24.8K
|
26.4K
$23.3K
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
400+ 1.97% |
$844 - $1.16K
|
20.7K
$18.2K
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
100+ 0.12% |
$211 - $290
|
84.8K
$74.6K
|
|
Nov 02, 2023
Q3 2023
|
Cullen/Frost Bankers, Inc.
|
BUY
|
- |
100New |
$211 - $290
|
100
$88
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
21+ 0.78% |
$44.3 - $60.9
|
2.72K
$2.4K
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
19+ 23.46% |
$40.1 - $55.1
|
100
$88
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
4New |
$8.44 - $11.6
|
4
$3.52
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-512- 11.65% |
$1.08K - $1.48K
|
3.88K
$3.42K
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-751- 2.78% |
$1.58K - $2.18K
|
26.3K
$23.1K
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.23K- 77.81% |
$2.59K - $3.56K
|
350
$308
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.83K- 3.71% |
$3.85K - $5.3K
|
47.4K
$41.7K
|